WELCOME TO The HEALTHCARE REPORT
Baptist Health Care
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Ventech Solutions | November 19, 2020
Ventech Solutions, Inc. furthermore, Regenstrief Institute are cooperating to create, validate and convey high-performance health information advancements to improve health and healthcare. The partnership will make and minister information solutions and datasets to advance populace health and results research.
Olive | August 13, 2021
Olive, the automation company creating the Internet of Healthcare, announced a strategic relationship today with Amazon Web Services, Inc. (AWS) to leverage cloud computing to make healthcare more efficient and affordable for patients and organizations. Running on AWS, Olive's workflow automation solution connects data between disparate systems and networks, including health systems, payers, data, and patient information and history. Olive's HIPAA-compliant environment, which runs on ...
healthpayerintelligence | January 23, 2020
Centene and WellCare announced they have finalized a major health payer merger deal that will combine the two organizations into the largest health insurer by membership with more than 24 million covered individuals. The finalized merger deal follows 10 months after the March 2019 announcement saying Centene planned to acquire WellCare for $17.3 billion in cash and stock to bolster and diversify product offerings, increase sales, and have access to new markets which would enhance value-bas...
Bio Products Laboratory | May 29, 2020
Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies with US headquarters in Durham, North Carolina, and worldwide headquarters and manufacturing facilities in Elstree, UK, today announced the US launch of ALBUMINEX 5% (human albumin) solution for injection and ALBUMINEX 25% (human albumin) solution for injection, with supply immediately available. ALBUMINEX 5% and ALBUMINEX 25% are approved by the US Food and Drug Administration for the treatment of hypovole...
FUTURE OF HEALTHCARE
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE